As you have referred to a buy out analogy can you tell us , in your experience, at what stage of development could RAC be a realistic target ?
Are there examples out there of very early buyouts in this sector ?
Bisantrene seems to be a very promising drug .
Im perhaps trying to work out the “safest” entry point to the stock
I am very aware the returns can be better the earlier you enter , am also aware it takes many trials , money(raisings) etc to develop .
( an example is the recent PAR thread )
ASH2023 - Sheba 2.0, page-129
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
-0.005(0.34%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.50 | $1.46 | $129.2K | 87.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7418 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 38353 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |